Vaccination

FDA advisers back Novavax COVID shots as 4th US option

American adults who haven't yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.

Vaccination

FDA panel meets to craft future vaccine strategy

An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country's current shots.

Vaccination

German panel recommends booster for recipients of 4 vaccines

Germany's independent vaccination advisory panel is recommending a booster shot with a messenger RNA vaccine for people who have had a full course of four Chinese, Indian and Russian COVID-19 vaccines that aren't currently ...

Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.

Vaccination

US advisers debate Pfizer boosters for younger teens

An influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike.

Vaccination

Germany vaccine panel OKs shots for children aged 5-11

Germany's independent vaccination advisory panel on Thursday said it was recommending COVID-19 shots for children aged 5 to 11 with pre-existing conditions or who are in close contact to vulnerable people.

Vaccination

Boosters for all adults in US closer with panel meeting set

An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend.

page 4 from 11